Bosnian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

ataxia/atrofija

Veza se sprema u međuspremnik
Page 1 od 39 rezultati

Pharmaceutical composition for treating spinocerebellar ataxia

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
TECHNICAL FIELD The present invention relates to a pharmaceutical composition for treating spinocerebellar ataxia (or atrophy, degeneration) or multiple system atrophy, or for improving ataxia or equilibrium disturbance. BACKGROUND ART Spinocerebellar ataxia (SCA) includes neurodegeneration diseases

Remedies for spinocerebellar ataxia and compositions for treating spinocerebellar ataxia

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
This is a 371 of PCT/JP99/02971 field Jun. 3, 1999. Technical Field The present invention relates to a remedy for treatment of spinocerebellar degeneration comprising D-cycloserine, D-serine or D-serine ester as an active ingredient, a composition for treatment of spinocerebellar degeneration

Activators of class I histone deacetlyases (HDACs) and uses thereof

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
FIELD OF THE INVENTION The field of the invention pertains to activators of class I histone deacetylases and their uses in the treatment of neurological disorders. BACKGROUND OF THE INVENTION In a variety of neurodegenerative disorders such as ischemia and Alzheimer's disease (Hayashi et al.,

Use of famotidine and related compounds in the treatment of movement disorders

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
INTRODUCTION The present invention relates to methods of treating movement disorders which utilize famotidine or famotidine-related compounds. It is based, at least in part, on the discovery that famotidine ameliorates the symptoms and signs of Parkinson's Disease. In preferred embodiments of the

Method for treating neurodegeneration using a p38MAPK inhibitor

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Jun. 23, 2014, is named 117735-02202_SL.txt and is 1,218 bytes in size. INTRODUCTION A-T

Desferrithiocin analogs and uses thereof

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND OF THE INVENTION Nearly all life forms require iron as a micronutrient. However, the low solubility of Fe(III) hydroxide (K.sub.sp=1.times.10.sup.-39) (Raymond et al., "Coordination Chemistry and Microbial Iron Transport." Acc. Chem. Res. 1979, 12, 183-190), the predominant form of the

Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND OF THE INVENTION Neurogenesis occurs in the developing and adult brain. Conceptually, this process of neurogenesis can be divided into four steps: (i) proliferation of NSCs; (ii) neuronal fate determination of NSC; (iii) survival and maturation of new neurons; and (iv) functional

1,7-naphthyridine derivatives

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
CROSS REFERENCE TO RELATED APPLICATIONS This application is a continuation of International Application No. PCT/EP2014/066123 having an international filing date of Jul. 28, 2014 and which claims benefit under 35 U.S.C. .sctn.119 to European Patent Application No. 13178373.0 filed Jul. 29, 2013. The

Benzisoxazoles

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND OF THE INVENTION Now it has been shown that the present compounds stimulate neurogenesis from neural stem cells (NSCs). Neurogenesis occurs in the developing and adult brain. Conceptually, this process of neurogenesis can be divided into four steps: (i) proliferation of NSCs; (ii)

Imidazopyridine derivatives

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
The present invention relates to compounds of general formula ##STR00002## wherein Ar is phenyl or pyridinyl; X.sup.1 is N or CH, X.sup.2 is N or CH, with the proviso that only one of X.sup.1 or X.sup.2 is N and the other is CH; R.sup.1 is hydrogen, halogen, lower alkyl, lower alkoxy, lower alkyl

Isoquinoline derivatives

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
The present invention relates to the use of compounds of general formula ##STR00002## wherein R.sup.1 is phenyl or pyridinyl, which are optionally substituted by halogen, cyano or lower alkyl substituted by halogen, or is dihydro-pyran-4-yl; R.sup.2 is hydrogen or lower alkyl; R.sup.3 is

Pro-neurogenic compounds

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
TECHNICAL FIELD This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of

Pro-neurogenic compounds

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
TECHNICAL FIELD This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of

Pro-neurogenic compounds

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
TECHNICAL FIELD This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of newly formed neurons

Pro-neurogenic compounds

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
TECHNICAL FIELD This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of
Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta naukom

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti naukom
  • Prepoznavanje biljaka po slici
  • Interaktivna GPS karta - označite bilje na lokaciji (uskoro)
  • Pročitajte naučne publikacije povezane sa vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoja interesovanja i budite u toku sa istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Sve informacije temelje se na objavljenim naučnim istraživanjima

Google Play badgeApp Store badge